Cancer patients' lymphocytes contain CD3+CD4+cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells
暂无分享,去创建一个
S. Andreola | M. Quaia | E. Galligioni | G. Parmiani | M. Radrizzani | G. Fossati | M. Vaglini | B. Benedetti